nVNS, CBD, and SoC for Persistent Post-Traumatic Headache
Public ClinicalTrials.gov record NCT07624279. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Multicenter Study of Non-Invasive Vagus Nerve Stimulation (nVNS), Cannabidiol, and Standard of Care for the Treatment of Persistent Post-Traumatic Headache in Elite Athletes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Do cannabidiol (CBD) or vagus nerve stimulation reduce the frequency of persistent post-traumatic headache more than traditional oral headache medications?
Study identification
- NCT ID
- NCT07624279
- Recruitment status
- Not yet recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 80 participants
Conditions and interventions
Conditions
Interventions
- Non-Invasive Vagus Nerve Stimulation Device
- Cannabidiol Drug
- Standard of Care Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 1, 2026 (Estimated)
- Primary completion
- Jul 31, 2027 (Estimated)
- Completion
- Jul 1, 2028 (Estimated)
- Last update posted
- Jun 3, 2026
2026 – 2028
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic | Scottsdale | Arizona | 85054 | — |
| Kerlan-Jobe Orthopaedic Institute | Los Angeles | California | 90045 | — |
| International Spine, Pain & Performance Center | Washington D.C. | District of Columbia | 20006 | — |
| Florida Spine & Pain Specialists | Tampa | Florida | 33614 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| Premier Pain Center | Shrewsbury | New Jersey | 07702 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Allegheny General Hospital | Pittsburgh | Pennsylvania | 15212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07624279, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 3, 2026 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07624279 live on ClinicalTrials.gov.